Related Experiment Video
Updated: Mar 16, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
A Plan to Improve Melanoma Tumor Depth Data Quality in the Surveillance, Epidemiology, and End Results Program
Abstract:
In light of the recent assessment done for ProstateSpecific Antigen values in the Surveillance, Epidemiology, and End Results (SEER) Program, it is possible that coding procedures for melanoma tumor depth may have similar quality issues. Potential errors that have been initially identified are implied decimal errors, transcription errors, and incomplete information. Because of the SEER Program's commitment to high data quality standards, various studies are being planned to review and adjudicate incorrect lab values for several different data items in the SEER data collection.
Insights
Quality issues in melanoma tumor depth coding within the Surveillance, Epidemiology, and End Results (SEER) Program are suspected, similar to Prostate-Specific Antigen values. Studies are planned to review and correct potential errors in SEER data.
Area of Science:
- Oncology
- Cancer Epidemiology
- Biostatistics
Background:
- The Surveillance, Epidemiology, and End Results (SEER) Program collects cancer data.
- Recent assessments revealed potential quality issues with Prostate-Specific Antigen (PSA) values in SEER data.
- Similar coding issues may affect other SEER data items, including melanoma tumor depth.
Purpose of the Study:
- To investigate potential coding quality issues for melanoma tumor depth in the SEER Program.
- To identify specific types of errors in melanoma tumor depth coding.
- To inform data quality improvement initiatives within the SEER Program.
Main Methods:
- Review of SEER Program data coding procedures for melanoma.
- Identification of potential error types, including decimal errors, transcription errors, and incomplete data.
- Planning of studies to adjudicate and correct identified data inaccuracies.
Main Results:
- Potential coding errors for melanoma tumor depth have been identified.
- Specific error types include implied decimal errors, transcription errors, and incomplete information.
- Further studies are planned for data adjudication and correction.
Conclusions:
- Melanoma tumor depth coding in the SEER Program may be subject to quality issues.
- Proactive measures, including planned studies, are necessary to ensure SEER data accuracy.
- Maintaining high data quality standards is crucial for cancer surveillance and research.
